A detailed history of Quantbot Technologies LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 7,706 shares of ARWR stock, worth $151,268. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,706
Holding current value
$151,268
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $149,188 - $227,635
7,706 New
7,706 $149,000
Q2 2022

Aug 09, 2022

BUY
$27.79 - $50.61 $2,751 - $5,010
99 Added 1.29%
7,800 $274,000
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $301,191 - $531,911
7,602 Added 7678.79%
7,701 $354,000
Q4 2021

Feb 11, 2022

BUY
$58.09 - $82.51 $5,750 - $8,168
99 New
99 $6,000
Q3 2021

Nov 09, 2021

SELL
$58.38 - $84.96 $139,061 - $202,374
-2,382 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$62.15 - $90.32 $148,041 - $215,142
2,382 New
2,382 $197,000
Q1 2021

May 14, 2021

SELL
$61.35 - $90.47 $46,196 - $68,123
-753 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$43.82 - $85.37 $32,996 - $64,283
753 New
753 $57,000
Q2 2020

Aug 13, 2020

SELL
$26.12 - $43.27 $1,488 - $2,466
-57 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$20.56 - $63.12 $1,171 - $3,597
57 New
57 $1,000
Q4 2018

Feb 13, 2019

SELL
$10.74 - $19.7 $45,483 - $83,429
-4,235 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$14.0 - $20.3 $25,368 - $36,783
-1,812 Reduced 29.97%
4,235 $81,000
Q2 2018

Aug 13, 2018

BUY
$6.37 - $14.02 $38,519 - $84,778
6,047 New
6,047 $82,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.